OSAM
IMUX icon

O'Shaughnessy Asset Management’s Immunic IMUX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed – – 2790
2021
Q2 		$0 Hold
2
– – ﹤0.01% 2637
2021
Q1 		$0 Sell
2
-1
-33% -$170 ﹤0.01% 2412
2020
Q4 		$0 Buy
+3
New +$539 ﹤0.01% 2147

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

O'Shaughnessy Asset Management's IMUX Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Immunic (IMUX) in Q3 2021, closing a stake of 2 shares.

O'Shaughnessy Asset Management first reported a position in IMUX in Q4 2020 and held it in 3 quarters. The position peaked at $0 in Q2 2021. 68 funds tracked by Wall St. Rank hold IMUX as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining Immunic position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 2 Immunic shares in Q3 2021.
  • O'Shaughnessy Asset Management first reported a position in Immunic in Q4 2020 and held it in 3 quarters.
  • O'Shaughnessy Asset Management's Immunic position peaked at $0 in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Immunic as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.